Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Honeywell International Inc.

www.honeywell.com

Latest From Honeywell International Inc.

Deals Shaping The Medical Industry, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2015.

BioPharmaceutical Medical Device

European Notebook: Pricing Mistrust Needs Open Debate; Rasi Nears EMA Return; Market Turmoil Affects IPOs

The EU’s Health Commissioner called for an open debate on pharmaceutical pricing with industry, while Guido Rasi prepares for part two of helming the European Medicines Agency and German big pharmas Bayer and Merck KGaA completed business restructuring. More developments in this month's column.

BioPharmaceutical Belgium

Cosmetic Suppliers Adopt New Strategies For Existing Ingredients

Due to a challenging economy, new ingredient launches at the in-cosmetics trade show were down, compared with previous years. Instead, suppliers are extending actives into new application areas, reformatting ingredients and reintroducing ingredients to companies with new management or adjusted priorities.

Consumer Europe

Eyeing Both A Partnership And An IPO, Aragon Takes $42M Series C

A well-connected fund that invests on behalf of a group of high-net-worth investors provides cash to complete a Phase II trial on prostate cancer drug ARN-509, and bring a breast cancer drug into the clinic.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Diversified
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Honeywell International Inc.
  • Senior Management
  • David M Cote, Chmn., Pres. & CEO
    Thomas A Szlosek, SVP, CFO
  • Contact Info
  • Honeywell International Inc.
    Phone: (973) 455-2000
    101 Columbia Rd.
    P.O. Box 4000 Morristown , NJ 07962-2497
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register